01 8AstraZeneca Canada Inc.
01 22296665
02 22351709
03 22408596
04 22659328
01 4TICAGRELOR
02 4Ticagrelor
01 4TABLET
02 4Tablet
01 22018-07-15
02 22019-12-02
03 22021-05-31
04 22027-08-20
Patent Expiration Date : 2021-05-31
Date Granted : 2010-12-21
Brand Name : BRILINTA
Patent Number : 2408596
Filing Date : 2001-05-31
Strength per Unit : 90 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2021-05-31
Date Granted : 2010-12-21
Patent Expiration Date : 2019-12-02
Date Granted : 2010-04-06
Brand Name : BRILINTA
Patent Number : 2351709
Filing Date : 1999-12-02
Strength per Unit : 90 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2019-12-02
Date Granted : 2010-04-06
Patent Expiration Date : 2018-07-15
Date Granted : 2008-06-10
Brand Name : BRILINTA
Patent Number : 2296665
Filing Date : 1998-07-15
Strength per Unit : 90 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-07-15
Date Granted : 2008-06-10
Patent Expiration Date : 2027-08-20
Date Granted : 2015-08-11
Brand Name : BRILINTA
Patent Number : 2659328
Filing Date : 2007-08-20
Strength per Unit : 90 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2027-08-20
Date Granted : 2015-08-11
Patent Expiration Date : 2027-08-20
Date Granted : 2015-08-11
Brand Name : BRILINTA
Patent Number : 2659328
Filing Date : 2007-08-20
Strength per Unit : 60 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2027-08-20
Date Granted : 2015-08-11
Patent Expiration Date : 2021-05-31
Date Granted : 2010-12-21
Brand Name : BRILINTA
Patent Number : 2408596
Filing Date : 2001-05-31
Strength per Unit : 60 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2021-05-31
Date Granted : 2010-12-21
Patent Expiration Date : 2019-12-02
Date Granted : 2010-04-06
Brand Name : BRILINTA
Patent Number : 2351709
Filing Date : 1999-12-02
Strength per Unit : 60 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2019-12-02
Date Granted : 2010-04-06
Patent Expiration Date : 2018-07-15
Date Granted : 2008-06-10
Brand Name : BRILINTA
Patent Number : 2296665
Filing Date : 1998-07-15
Strength per Unit : 60 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2018-07-15
Date Granted : 2008-06-10
